Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

A longitudinal study of CMT1A using Rasch analysis based CMT neuropathy and examination scores.

Fridman V, Sillau S, Acsadi G, Bacon C, Dooley K, Burns J, Day J, Feely S, Finkel RS, Grider T, Gutmann L, Herrmann DN, Kirk CA, Knause SA, Laurá M, Lewis RA, Li J, Lloyd TE, Moroni I, Muntoni F, Pagliano E, Pisciotta C, Piscosquito G, Ramchandren S, Saporta M, Sadjadi R, Shy RR, Siskind CE, Sumner CJ, Walk D, Wilcox J, Yum SW, Züchner S, Scherer SS, Pareyson D, Reilly MM, Shy ME; Inherited Neuropathies Consortium—Rare Diseases Clinical Research Network (INC-RDCRN).

Neurology. 2020 Feb 11. pii: 10.1212/WNL.0000000000009035. doi: 10.1212/WNL.0000000000009035. [Epub ahead of print]

PMID:
32047073
2.

Comparison of Integrated Outpatient Palliative Care With Standard Care in Patients With Parkinson Disease and Related Disorders: A Randomized Clinical Trial.

Kluger BM, Miyasaki J, Katz M, Galifianakis N, Hall K, Pantilat S, Khan R, Friedman C, Cernik W, Goto Y, Long J, Fairclough D, Sillau S, Kutner JS.

JAMA Neurol. 2020 Feb 10. doi: 10.1001/jamaneurol.2019.4992. [Epub ahead of print]

PMID:
32040141
3.

Incidence and Clinical Outcomes of Streptococcus anginosus in Acute Complicated Sinusitis: A Pediatric Cohort.

Troy E, Sillau S, Bernard TJ, Rao S.

J Pediatric Infect Dis Soc. 2020 Jan 11. pii: piz098. doi: 10.1093/jpids/piz098. [Epub ahead of print]

PMID:
31925948
4.

Risk of spread in adult-onset isolated focal dystonia: a prospective international cohort study.

Berman BD, Groth CL, Sillau SH, Pirio Richardson S, Norris SA, Junker J, Brüggemann N, Agarwal P, Barbano RL, Espay AJ, Vizcarra JA, Klein C, Bäumer T, Loens S, Reich SG, Vidailhet M, Bonnet C, Roze E, Jinnah HA, Perlmutter JS.

J Neurol Neurosurg Psychiatry. 2020 Mar;91(3):314-320. doi: 10.1136/jnnp-2019-321794. Epub 2019 Dec 17.

5.

Patient and caregiver characteristics associated with caregiver burden in Parkinson's disease: a palliative care approach.

Macchi ZA, Koljack CE, Miyasaki JM, Katz M, Galifianakis N, Prizer LP, Sillau SH, Kluger BM.

Ann Palliat Med. 2019 Nov 14. pii: apm.2019.10.01. doi: 10.21037/apm.2019.10.01. [Epub ahead of print]

6.

Correlates of spiritual wellbeing in persons living with Parkinson disease.

Prizer LP, Kluger BM, Sillau S, Katz M, Galifianakis N, Miyasaki JM.

Ann Palliat Med. 2019 Nov 4. pii: apm.2019.09.13. doi: 10.21037/apm.2019.09.13. [Epub ahead of print]

7.

Hemodynamic responses are abnormal in isolated cervical dystonia.

Berman BD, Groth CL, Shelton E, Sillau SH, Sutton B, Legget KT, Tregellas JR.

J Neurosci Res. 2020 Apr;98(4):692-703. doi: 10.1002/jnr.24547. Epub 2019 Nov 6.

PMID:
31692015
8.

The feasibility of a multidisciplinary group therapy clinic for the treatment of nonepileptic seizures.

Libbon R, Gadbaw J, Watson M, Rothberg B, Sillau S, Heru A, Strom L.

Epilepsy Behav. 2019 Sep;98(Pt A):117-123. doi: 10.1016/j.yebeh.2019.06.032. Epub 2019 Jul 29.

PMID:
31369968
9.

Feasibility of Home-Based Neurologic Music Therapy for Behavioral and Psychological Symptoms of Dementia: A Pilot Study.

Holden SK, Sheffler J, Stewart R, Thompson S, Persson J, Finseth T, Sillau S, Kluger BM.

J Music Ther. 2019 Aug 13;56(3):265-286. doi: 10.1093/jmt/thz009.

PMID:
31346625
10.

Measuring quality of life in palliative care for Parkinson's disease: A clinimetric comparison.

Holden SK, Koljack CE, Prizer LP, Sillau SH, Miyasaki JM, Kluger BM.

Parkinsonism Relat Disord. 2019 Aug;65:172-177. doi: 10.1016/j.parkreldis.2019.06.018. Epub 2019 Jun 23.

PMID:
31253494
11.

The Multiple Sclerosis Severity Score: fluctuations and prognostic ability in a longitudinal cohort of patients with MS.

Gross RH, Sillau SH, Miller AE, Farrell C, Krieger SC.

Mult Scler J Exp Transl Clin. 2019 Mar 18;5(1):2055217319837254. doi: 10.1177/2055217319837254. eCollection 2019 Jan-Mar.

12.

Response to Ajay Kumar Mishra, et al. Lacunar strokes in Cryptococcal meningitis.

Vela-Duarte D, Nyberg E, Sillau S, Pate A, Castellanos P, Chastain DB, Franco-Paredes C, Henao-Martínez AF.

J Stroke Cerebrovasc Dis. 2019 Jun;28(6):1785-1786. doi: 10.1016/j.jstrokecerebrovasdis.2019.02.038. Epub 2019 Mar 19. No abstract available.

PMID:
30898446
13.

Is Prevalence of Atherosclerotic Risk Factors Increasing Among Young Adults? It Depends on How You Ask.

Leppert MH, Poisson SN, Sillau SH, Campbell JD, Ho PM, Burke JF.

J Am Heart Assoc. 2019 Mar 19;8(6):e010883. doi: 10.1161/JAHA.118.010883.

14.

Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatment.

Vollmer BL, Nair KV, Sillau S, Corboy JR, Vollmer T, Alvarez E.

Ann Clin Transl Neurol. 2018 Dec 9;6(2):252-262. doi: 10.1002/acn3.700. eCollection 2019 Feb.

15.

Defining Palliative Care Needs in Parkinson's Disease.

Kluger BM, Shattuck J, Berk J, Sebring K, Jones W, Brunetti F, Fairmont I, Bowles DW, Sillau S, Bekelman DB.

Mov Disord Clin Pract. 2018 Nov 16;6(2):125-131. doi: 10.1002/mdc3.12702. eCollection 2019 Feb.

16.

Feasibility of home-based automated transcranial electrical stimulation during slow wave sleep.

McConnell BV, Kaplan RI, Teale PD, Kronberg E, Broussard JL, Guzetti JR, Sillau SH, Dhanasekaran AR, Kluger BM, Berman BD.

Brain Stimul. 2019 May - Jun;12(3):813-815. doi: 10.1016/j.brs.2019.02.014. Epub 2019 Feb 20. No abstract available.

PMID:
30819658
17.

Does outpatient palliative care improve patient-centered outcomes in Parkinson's disease: Rationale, design, and implementation of a pragmatic comparative effectiveness trial.

Kluger BM, Katz M, Galifianakis N, Pantilat SZ, Kutner JS, Sillau S, Gritz M, Jones J, Fairclough D, Sumrall M, Hall K, Miyasaki J.

Contemp Clin Trials. 2019 Apr;79:28-36. doi: 10.1016/j.cct.2019.02.005. Epub 2019 Feb 16.

PMID:
30779960
18.

Education Research: Neuroradiology curriculum in neurology residency training programs: How we teach neuroimaging.

Johnson PD, Sillau S, Masdeu JC, Ney DE, Korb PJ.

Neurology. 2019 Jan 22;92(4):199-203. doi: 10.1212/WNL.0000000000006812.

19.

Lacunar Stroke in Cryptococcal Meningitis: Clinical and Radiographic Features.

Vela-Duarte D, Nyberg E, Sillau S, Pate A, Castellanos P, Chastain DB, Franco-Paredes C, Henao-Martínez AF.

J Stroke Cerebrovasc Dis. 2019 Jun;28(6):1767-1772. doi: 10.1016/j.jstrokecerebrovasdis.2018.12.043. Epub 2019 Jan 14.

PMID:
30655043
20.

Rituximab vs placebo induction prior to glatiramer acetate monotherapy in multiple sclerosis.

Honce JM, Nair KV, Sillau S, Valdez B, Miravalle A, Alvarez E, Schreiner T, Corboy JR, Vollmer TL.

Neurology. 2019 Feb 12;92(7):e723-e732. doi: 10.1212/WNL.0000000000006916. Epub 2019 Jan 11.

21.

Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal.

Weinkle L, Domen CH, Shelton I, Sillau S, Nair K, Alvarez E.

Mult Scler Relat Disord. 2019 Jan;27:383-390. doi: 10.1016/j.msard.2018.11.022. Epub 2018 Nov 20.

PMID:
30502644
22.

Yield of laboratory testing in pediatric ketogenic diet patients: Critical assessment of abnormal results and impact on clinical care.

Joshi C, Stillman C, Criteser S, Oliver J, Conley A, Sillau S, Zupec-Kania B.

Epilepsy Res. 2019 Jan;149:70-75. doi: 10.1016/j.eplepsyres.2018.11.007. Epub 2018 Nov 16.

PMID:
30500489
23.

Safety, tolerability, and efficacy of fluoxetine as an antiviral for acute flaccid myelitis.

Messacar K, Sillau S, Hopkins SE, Otten C, Wilson-Murphy M, Wong B, Santoro JD, Treister A, Bains HK, Torres A, Zabrocki L, Glanternik JR, Hurst AL, Martin JA, Schreiner T, Makhani N, DeBiasi RL, Kruer MC, Tremoulet AH, Van Haren K, Desai J, Benson LA, Gorman MP, Abzug MJ, Tyler KL, Dominguez SR.

Neurology. 2019 Apr 30;92(18):e2118-e2126. doi: 10.1212/WNL.0000000000006670. Epub 2018 Nov 9.

PMID:
30413631
24.

Association of MRI Measurements with Cognitive Outcomes After STN-DBS in Parkinson's Disease.

Weinkle LJ, Hoyt B, Thompson JA, Sillau S, Tanabe J, Honce J, Klepitskaya O.

Mov Disord Clin Pract. 2018 Jul 28;5(4):417-426. doi: 10.1002/mdc3.12643. eCollection 2018 Jul-Aug.

25.

Validation of a performance-based assessment of cognitive functional ability in Parkinson's disease.

Holden SK, Medina LD, Hoyt B, Sillau SH, Berman BD, Goldman JG, Weintraub D, Kluger BM.

Mov Disord. 2018 Nov;33(11):1760-1768. doi: 10.1002/mds.27487. Epub 2018 Oct 10.

26.

Discontinuation and comparative effectiveness of dimethyl fumarate and fingolimod in 2 centers.

Vollmer B, Ontaneda D, Bandyopadhyay A, Cohn S, Nair K, Sillau S, Bermel RA, Corboy JR, Fox RJ, Vollmer T, Cohen JA, Alvarez E, Hersh CM.

Neurol Clin Pract. 2018 Aug;8(4):292-301. doi: 10.1212/CPJ.0000000000000487.

27.

Deep brain stimulation improves restless legs syndrome in patients with Parkinson disease.

Klepitskaya O, Liu Y, Sharma S, Sillau SH, Tsai J, Walters AS.

Neurology. 2018 Sep 11;91(11):e1013-e1021. doi: 10.1212/WNL.0000000000006162. Epub 2018 Aug 15. Erratum in: Neurology. 2019 Apr 30;92(18):871.

PMID:
30111549
28.

Assessing the validity of proxy caregiver reporting for potential palliative care outcome measures in Parkinson's disease.

Sebring K, Shattuck J, Berk J, Boersma I, Sillau S, Kluger BM.

Palliat Med. 2018 Oct;32(9):1522-1528. doi: 10.1177/0269216318785830. Epub 2018 Jul 17.

PMID:
30015552
29.

Isolated focal dystonia phenotypes are associated with distinct patterns of altered microstructure.

Berman BD, Honce JM, Shelton E, Sillau SH, Nagae LM.

Neuroimage Clin. 2018 Jun 5;19:805-812. doi: 10.1016/j.nicl.2018.06.004. eCollection 2018.

30.

The impact of very short transition times on switching from Natalizumab to Fingolimod on imaging and clinical effectiveness outcomes in multiple sclerosis.

Vollmer B, Honce JM, Sillau S, Corboy JR, Vollmer T, Nair K, Alvarez E.

J Neurol Sci. 2018 Jul 15;390:89-93. doi: 10.1016/j.jns.2018.04.021. Epub 2018 Apr 13.

PMID:
29801915
31.

Progression of MDS-UPDRS Scores Over Five Years in De Novo Parkinson Disease from the Parkinson's Progression Markers Initiative Cohort.

Holden SK, Finseth T, Sillau SH, Berman BD.

Mov Disord Clin Pract. 2018 Jan-Feb;5(1):47-53. doi: 10.1002/mdc3.12553. Epub 2017 Sep 22.

32.

Seizure Severity Is Correlated With Severity of Hypoxic-Ischemic Injury in Abusive Head Trauma.

Dingman AL, Stence NV, O'Neill BR, Sillau SH, Chapman KE.

Pediatr Neurol. 2018 May;82:29-35. doi: 10.1016/j.pediatrneurol.2017.12.003. Epub 2017 Dec 12.

PMID:
29625848
33.

Transcranial magnetic stimulation does not improve mild cognitive impairment in Parkinson's disease.

Buard I, Sciacca DM, Martin CS, Rogers S, Sillau SH, Greher MR, Chen R, Kluger BM.

Mov Disord. 2018 Mar;33(3):489-491. doi: 10.1002/mds.27246. Epub 2017 Nov 27. No abstract available.

34.

Comparison of fingolimod and dimethyl fumarate in the treatment of multiple sclerosis: Two-year experience.

Vollmer B, Nair KV, Sillau SH, Corboy J, Vollmer T, Alvarez E.

Mult Scler J Exp Transl Clin. 2017 Aug 17;3(3):2055217317725102. doi: 10.1177/2055217317725102. eCollection 2017 Jul-Sep.

35.

New-onset seizure during and after brain tumor excision: a risk assessment analysis.

Oushy S, Sillau SH, Ney DE, Damek DM, Youssef AS, Lillehei KO, Ormond DR.

J Neurosurg. 2018 Jun;128(6):1713-1718. doi: 10.3171/2017.2.JNS162315. Epub 2017 Jul 28.

PMID:
28753117
36.

Outcomes of Colorado children with acute flaccid myelitis at 1 year.

Martin JA, Messacar K, Yang ML, Maloney JA, Lindwall J, Carry T, Kenyon P, Sillau SH, Oleszek J, Tyler KL, Dominguez SR, Schreiner TL.

Neurology. 2017 Jul 11;89(2):129-137. doi: 10.1212/WNL.0000000000004081. Epub 2017 Jun 14.

37.

Preoperative evaluation for epilepsy surgery: Process improvement.

Drees C, Sillau S, Brown MG, Abosch A.

Neurol Clin Pract. 2017 Jun;7(3):205-213. doi: 10.1212/CPJ.0000000000000357.

38.

Psychiatric associations of adult-onset focal dystonia phenotypes.

Berman BD, Junker J, Shelton E, Sillau SH, Jinnah HA, Perlmutter JS, Espay AJ, Jankovic J, Vidailhet M, Bonnet C, Ondo W, Malaty IA, Rodríguez R, McDonald WM, Marsh L, Zurowski M, Bäumer T, Brüggemann N.

J Neurol Neurosurg Psychiatry. 2017 Jul;88(7):595-602. doi: 10.1136/jnnp-2016-315461. Epub 2017 Apr 24.

39.

Spheno-Orbital Meningiomas: A 16-Year Surgical Experience.

Freeman JL, Davern MS, Oushy S, Sillau S, Ormond DR, Youssef AS, Lillehei KO.

World Neurosurg. 2017 Mar;99:369-380. doi: 10.1016/j.wneu.2016.12.063. Epub 2016 Dec 23.

PMID:
28017748
40.

Inpatient Palliative Care for Neurological Disorders: Lessons from a Large Retrospective Series.

Liu Y, Kline D, Aerts S, Youngwerth JM, Kutner JS, Sillau S, Kluger BM.

J Palliat Med. 2017 Jan;20(1):59-64. Epub 2016 Nov 29.

PMID:
27898260
41.

Invasive Giant Cell Tumor of the Lateral Skull Base: A Systematic Review, Meta-Analysis, and Case Illustration.

Freeman JL, Oushy S, Schowinsky J, Sillau S, Youssef AS.

World Neurosurg. 2016 Dec;96:47-57. doi: 10.1016/j.wneu.2016.05.086. Epub 2016 Jun 4. Review.

PMID:
27269210
42.

Clinical Examination of Tissue Eosinophilia in Patients with Chronic Rhinosinusitis and Nasal Polyposis.

Gitomer SA, Fountain CR, Kingdom TT, Getz AE, Sillau SH, Katial RK, Ramakrishnan VR.

Otolaryngol Head Neck Surg. 2016 Jul;155(1):173-8. doi: 10.1177/0194599816637856. Epub 2016 Mar 15.

PMID:
26980909
43.

Microstructural Changes within the Basal Ganglia Differ between Parkinson Disease Subtypes.

Nagae LM, Honce JM, Tanabe J, Shelton E, Sillau SH, Berman BD.

Front Neuroanat. 2016 Feb 23;10:17. doi: 10.3389/fnana.2016.00017. eCollection 2016.

44.

The Colorado-retinopathy of prematurity model (CO-ROP): postnatal weight gain screening algorithm.

Cao JH, Wagner BD, McCourt EA, Cerda A, Sillau S, Palestine A, Enzenauer RW, Mets-Halgrimson RB, Paciuc-Beja M, Gralla J, Braverman RS, Lynch A.

J AAPOS. 2016 Feb;20(1):19-24. doi: 10.1016/j.jaapos.2015.10.017.

PMID:
26917066
45.

Regression calibration with instrumental variables for longitudinal models with interaction terms, and application to air pollution studies.

Strand M, Sillau S, Grunwald GK, Rabinovitch N.

Environmetrics. 2015 Sep;26(6):393-405. Epub 2015 Aug 10.

46.

Characteristics of children under 2 years of age undergoing tonsillectomy for upper airway obstruction.

Côté V, Ruiz AG, Perkins J, Sillau S, Friedman NR.

Int J Pediatr Otorhinolaryngol. 2015 Jun;79(6):903-8. doi: 10.1016/j.ijporl.2015.04.003. Epub 2015 Apr 11.

PMID:
25912628
47.

Implications of the new American College of Cardiology/American Heart Association cholesterol guidelines for primary atherosclerotic cardiovascular disease event prevention in a multi ethnic cohort: Multi-Ethnic Study of Atherosclerosis (MESA).

Yeboah J, Sillau S, Delaney JC, Blaha MJ, Michos ED, Young R, Qureshi WT, McClelland R, Burke GL, Psaty BM, Herrington DM.

Am Heart J. 2015 Mar;169(3):387-395.e3. doi: 10.1016/j.ahj.2014.12.018. Epub 2015 Jan 6.

48.

25-Hydroxyvitamin D Concentration and Sleep Duration and Continuity: Multi-Ethnic Study of Atherosclerosis.

Bertisch SM, Sillau S, de Boer IH, Szklo M, Redline S.

Sleep. 2015 Aug 1;38(8):1305-11. doi: 10.5665/sleep.4914.

49.

Periodic limb movements during sleep and prevalent hypertension in the multi-ethnic study of atherosclerosis.

Koo BB, Sillau S, Dean DA 2nd, Lutsey PL, Redline S.

Hypertension. 2015 Jan;65(1):70-7. doi: 10.1161/HYPERTENSIONAHA.114.04193. Epub 2014 Oct 6.

50.

Significance of a positive family history for coronary heart disease in patients with a zero coronary artery calcium score (from the Multi-Ethnic Study of Atherosclerosis).

Cohen R, Budoff M, McClelland RL, Sillau S, Burke G, Blaha M, Szklo M, Uretsky S, Rozanski A, Shea S.

Am J Cardiol. 2014 Oct 15;114(8):1210-4. doi: 10.1016/j.amjcard.2014.07.043. Epub 2014 Jul 30.

Supplemental Content

Loading ...
Support Center